Firefly Neuroscience, Inc. - SIC # -

Ticker Exchange SIC # Website Latest Ticker
AIFF Nasdaq fireflyneuro.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Firefly Neuroscience, Inc.

Firefly Neuroscience Reports Third Quarter 2025 Financial Results - Nov 12th, 2025 5:45 am
Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America - Sep 5th, 2025 5:55 am
Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR’ Platform - Aug 26th, 2025 5:45 am
Cognito Therapeutics Presents Clinical Trial Data Highlighting Neuroprotective Potential of Spectris™ in Alzheimer’s Disease at AAIC 2025 - Jul 28th, 2025 6:00 am
Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research - Jul 14th, 2025 5:45 am
Stran & Company Appoints Veteran Financial Executive Brian M. Posner to its Board of Directors - Jul 10th, 2025 6:00 am
Firefly Neuroscience to be Added to the Russell Microcap® Index - Jun 23rd, 2025 6:05 am
Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients - Jun 20th, 2025 5:45 am
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - May 5th, 2025 7:00 pm
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - May 5th, 2025 5:45 am
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01 - Mar 6th, 2025 5:30 am
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million - Feb 21st, 2025 6:00 am
Firefly Neuroscience Accepted into NVIDIA Connect Program - Feb 11th, 2025 5:45 am
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics - Feb 7th, 2025 5:30 am
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care - Jan 24th, 2025 7:00 am
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform - Jan 14th, 2025 5:45 am
Firefly Neuroscience Closes on Financing of up to $12.4 Million - Dec 31st, 2024 7:00 am
Firefly Neuroscience Appoints Current Board Member, Greg Lipschitz, as Executive Chairman - Dec 4th, 2024 7:00 am